It is a trial of office-based, intravenous disodium ethylene-diamine-tetra-acetic acid (Na 2 EDTA) as a treatment for coronary artery disease (CAD). A few case series in the 1950s and early 1960s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback